Zealand Pharma shares surge after positive results of weight-loss drug that could contend with GLP-1s
Zealand Pharma said a second trial of patients on a higher dosage of its weight-loss drug showed an 8.6% drop in body weight.
Zealand Pharma said a second trial of patients on a higher dosage of its weight-loss drug showed an 8.6% drop in body weight.
